Preserved muscle oxidative capacity in COPD patients with hypoxemia treated by long term O2 therapy

By afschroeder • April 7, 2026

Adami A, Vitacca M, Casaburi R, Salvi B, Simonelli C, Rossiter HB, Paneroni M. Preserved muscle oxidative capacity in COPD patients with hypoxemia treated by long term O₂ therapy. Eur J Appl Physiol. 2026 Apr 6. doi: 10.1007/s00421-026-06227-4. Epub ahead of print. PMID: 41940949.

Tags: Chronic hypoxemia, Harbor UCLA, long-term oxygen therapy, Lung diffusing capacity for carbon monoxide, Near-infrared spectroscopy, Publications, Pulmonary, Critical Care & Sleep Medicine, Skeletal muscle, smokers

Rapid progression of coronary atherosclerosis across glycemic status: a serial coronary computed tomography angiography study from the PARADIGM registry

Won KB, Lee BK, Hadamitzky M, Kim YJ, Sung JM, Conte E, Pontone G, Andreini D, Budoff MJ, Gottlieb I, Chun EJ, Cademartiri F, Maffei[...]

Exercise intolerance and impaired aerobic capacity in heart transplant recipients

Kolkhorst FW, Cannon DT, Rossiter HB. Exercise intolerance and impaired aerobic capacity in heart transplant recipients. Exp Physiol. 2026 Oct 9:10.1113/EP093964. doi: 10.1113/EP093964. Epub ahead[...]

A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Multiple-Ascending Dose Study to Investigate the Safety, Tolerability, and Pharmacokinetics of DSTA4637S in Patients With Complicated Staphylococcus aureus Bacteremia Receiving Standard-of-Care Antibiotics

Miller LG, Fowler VG, Miro JM, Horcajada JP, Lewin-Koh N, Chu T, Rymut S, Gutierrez J, Rosenberger CM, Hazenbos WLW, Glickstein S, Couch JA, Peck[...]